136 related articles for article (PubMed ID: 26454804)
1. Increase of Intracellular BAFF in B Cells of Sjögren's Patients Is Not Affected by Decrease of BAFFR.
Krejsek J; Koláčková M; Lindrová I; Slezák R; Andrýs C
Acta Medica (Hradec Kralove); 2015; 58(1):25-31. PubMed ID: 26454804
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome.
Yoshimoto K; Tanaka M; Kojima M; Setoyama Y; Kameda H; Suzuki K; Tsuzaka K; Ogawa Y; Tsubota K; Abe T; Takeuchi T
Arthritis Res Ther; 2011; 13(5):R170. PubMed ID: 22018243
[TBL] [Abstract][Full Text] [Related]
3. Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome.
Pontarini E; Fabris M; Quartuccio L; Cappeletti M; Calcaterra F; Roberto A; Curcio F; Mavilio D; Della Bella S; De Vita S
Rheumatology (Oxford); 2015 Aug; 54(8):1429-34. PubMed ID: 25740829
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
[TBL] [Abstract][Full Text] [Related]
5. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
6. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
7. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
Cornec D; Costa S; Devauchelle-Pensec V; Jousse-Joulin S; Marcorelles P; Berthelot JM; Chiche L; Hachulla E; Hatron PY; Goeb V; Vittecoq O; Saraux A; Pers JO
J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
[TBL] [Abstract][Full Text] [Related]
8. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures.
Carrillo-Ballesteros FJ; Palafox-Sánchez CA; Franco-Topete RA; Muñoz-Valle JF; Orozco-Barocio G; Martínez-Bonilla GE; Gómez-López CE; Marín-Rosales M; López-Villalobos EF; Luquin S; Castañeda-Chávez A; Oregon-Romero E
Clin Exp Med; 2020 Nov; 20(4):615-626. PubMed ID: 32506205
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
[TBL] [Abstract][Full Text] [Related]
10. Decreased BAFF Receptor Expression and Unaltered B Cell Receptor Signaling in Circulating B Cells from Primary Sjögren's Syndrome Patients at Diagnosis.
Neys SFH; Verstappen GM; Bootsma H; Kroese FGM; Hendriks RW; Corneth OBJ
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563492
[TBL] [Abstract][Full Text] [Related]
11. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction.
Sharma A; Kiripolsky J; Klimatcheva E; Howell A; Fereidouni F; Levenson R; Rothstein TL; Kramer JM
Clin Immunol; 2016 Mar; 164():85-94. PubMed ID: 26826598
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF.
Szodoray P; Jellestad S; Alex P; Zhou T; Wilson PC; Centola M; Brun JG; Jonsson R
J Clin Immunol; 2004 Nov; 24(6):600-11. PubMed ID: 15622444
[TBL] [Abstract][Full Text] [Related]
13. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
[TBL] [Abstract][Full Text] [Related]
14. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
[TBL] [Abstract][Full Text] [Related]
15. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Ann Rheum Dis; 2007 May; 66(5):700-3. PubMed ID: 17040963
[TBL] [Abstract][Full Text] [Related]
16. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.
Ding J; Zhang W; Haskett S; Pellerin A; Xu S; Petersen B; Jandreski L; Hamann S; Reynolds TL; Zheng TS; Mingueneau M
Clin Immunol; 2016 Aug; 169():69-79. PubMed ID: 27352977
[TBL] [Abstract][Full Text] [Related]
17. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
d'Arbonneau F; Pers JO; Devauchelle V; Pennec Y; Saraux A; Youinou P
Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
[TBL] [Abstract][Full Text] [Related]
18. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study.
Seror R; Nocturne G; Lazure T; Hendel-Chavez H; Desmoulins F; Belkhir R; Ravaud P; Benbijja M; Poirier-Colame V; Taoufik Y; Mariette X
Arthritis Res Ther; 2015 Sep; 17(1):241. PubMed ID: 26336930
[TBL] [Abstract][Full Text] [Related]
19. Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival.
Lahiri A; Varin MM; Le Pottier L; Pochard P; Bendaoud B; Youinou P; Pers JO
J Autoimmun; 2014 Jun; 51():30-7. PubMed ID: 24602383
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
Brkic Z; Maria NI; van Helden-Meeuwsen CG; van de Merwe JP; van Daele PL; Dalm VA; Wildenberg ME; Beumer W; Drexhage HA; Versnel MA
Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
